Robitussin Buyers' Lack Of Receipts Dooms Labeling Cert.
By Henrik Nilsson · March 22, 2024, 10:57 PM EDT
A New York federal judge on Thursday denied class certification in litigation claiming GlaxoSmithKline lied about the "Maximum Strength" label on certain Robitussin cough syrup products, saying although the plaintiffs' lack...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login